MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meyer, E. L.
Right arrow Articles by Kellar, K. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meyer, E. L.
Right arrow Articles by Kellar, K. J.

Vol. 60, Issue 3, 568-576, September 2001

Agonist Regulation of Rat alpha 3beta 4 Nicotinic Acetylcholine Receptors Stably Expressed in Human Embryonic Kidney 293 Cells

Erin L. Meyer, Yingxian Xiao, and Kenneth J. Kellar

Department of Pharmacology, Georgetown University School of Medicine, Washington, DC

Effects of agonists on rat alpha 3beta 4 nicotinic acetylcholine receptors expressed in KXalpha 3beta 4R2 cells [human embryonic kidney 293-derived cells] were studied. The potencies of seven agonists varied over a 7000-fold range, with a rank order of epibatidine A85380 > cytisine approx  1,1-dimethyl-4-phenyl-piperazinium iodide (DMPP) approx  nicotine > acetylcholine > carbachol. The efficacies of all of the agonists studied here were similar except for DMPP, which seemed to be a partial agonist compared with nicotine and acetylcholine. Nicotine and carbachol desensitized the receptors in a time- and concentration-dependent manner. The EC50 values for nicotine and carbachol to desensitize the receptors during a 60-min exposure were 3 and 51 µM, respectively, indicating that these agonists are more potent at desensitizing the receptors than at activating them. The function of the receptors recovered from agonist-induced desensitization rapidly and almost completely. The half-time for recovery of function from desensitization after a 60-min treatment with nicotine increased with the concentration of nicotine used to desensitize the receptors. In contrast, no such concentration dependence for time to recovery of function was found when carbachol was used to desensitize the receptors. We propose that this difference may be due to the cell permeability of nicotine, allowing it to enter and be sequestered inside of cells and then slowly diffuse out to maintain receptor desensitization. After a 5-day exposure to 100 µM nicotine, the receptors were completely desensitized, but receptor function recovered to 83% of control values with a half-time of about 10.5 min. Although the number of nicotinic receptor binding sites measured with (±)-[3H]epibatidine was increased during the chronic treatment with nicotine, no increase in function was detected.


Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
M. Ohtani, T. Oka, M. Badyuk, Y. Xiao, K. J. Kellar, and J. W. Daly
Mouse beta-TC6 Insulinoma Cells: High Expression of Functional {alpha}3beta4 Nicotinic Receptors Mediating Membrane Potential, Intracellular Calcium, and Insulin Release
Mol. Pharmacol., March 1, 2006; 69(3): 899 - 907.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. M. Beckel, A. Kanai, S.-J. Lee, W. C. de Groat, and L. A. Birder
Expression of functional nicotinic acetylcholine receptors in rat urinary bladder epithelial cells
Am J Physiol Renal Physiol, January 1, 2006; 290(1): F103 - F110.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Kuryatov, J. Luo, J. Cooper, and J. Lindstrom
Nicotine Acts as a Pharmacological Chaperone to Up-Regulate Human {alpha}4{beta}2 Acetylcholine Receptors
Mol. Pharmacol., December 1, 2005; 68(6): 1839 - 1851.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. B. Free, S. B. McKay, P. D. Gottlieb, R. T. Boyd, and D. B. McKay
Expression of Native {alpha}3{beta}4* Neuronal Nicotinic Receptors: Binding and Functional Studies Investigating Turnover of Surface and Intracellular Receptor Populations
Mol. Pharmacol., June 1, 2005; 67(6): 2040 - 2048.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Alkondon and E. X. Albuquerque
Nicotinic Receptor Subtypes in Rat Hippocampal Slices Are Differentially Sensitive to Desensitization and Early in Vivo Functional Up-Regulation by Nicotine and to Block by Bupropion
J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 740 - 750.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
K. K. Rau, R. D. Johnson, and B. Y. Cooper
Nicotinic AChR in Subclassified Capsaicin-Sensitive and -Insensitive Nociceptors of the Rat DRG
J Neurophysiol, March 1, 2005; 93(3): 1358 - 1371.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. C. Hernandez, S. Vicini, Y. Xiao, M. I. Davila-Garcia, R. P. Yasuda, B. B. Wolfe, and K. J. Kellar
The Nicotinic Receptor in the Rat Pineal Gland Is an {alpha}3{beta}4 Subtype
Mol. Pharmacol., October 1, 2004; 66(4): 978 - 987.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Xiao and K. J. Kellar
The Comparative Pharmacology and Up-Regulation of Rat Neuronal Nicotinic Receptor Subtype Binding Sites Stably Expressed in Transfected Mammalian Cells
J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 98 - 107.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. L. Parker, Y. Fu, K. McAllen, J. Luo, J. M. McIntosh, J. M. Lindstrom, and B. M. Sharp
Up-Regulation of Brain Nicotinic Acetylcholine Receptors in the Rat during Long-Term Self-Administration of Nicotine: Disproportionate Increase of the {alpha}6 Subunit
Mol. Pharmacol., March 1, 2004; 65(3): 611 - 622.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. N. Nguyen, B. A. Rasmussen, and D. C. Perry
Subtype-Selective Up-Regulation by Chronic Nicotine of High-Affinity Nicotinic Receptors in Rat Brain Demonstrated by Receptor Autoradiography
J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 1090 - 1097.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. P. Boorman, M. Beato, P. J. Groot-Kormelink, S. D. Broadbent, and L. G. Sivilotti
The Effects of {beta}3 Subunit Incorporation on the Pharmacology and Single Channel Properties of Oocyte-expressed Human {alpha}3{beta}4 Neuronal Nicotinic Receptors
J. Biol. Chem., November 7, 2003; 278(45): 44033 - 44040.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. M. Avila, M. I. Davila-Garcia, V. S. Ascarrunz, Y. Xiao, and K. J. Kellar
Differential Regulation of Nicotinic Acetylcholine Receptors in PC12 Cells by Nicotine and Nerve Growth Factor
Mol. Pharmacol., October 1, 2003; 64(4): 974 - 986.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. W. Fitch, Y. Xiao, K. J. Kellar, and J. W. Daly
Membrane potential fluorescence: A rapid and highly sensitive assay for nicotinic receptor channel function
PNAS, April 15, 2003; 100(8): 4909 - 4914.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Abdrakhmanova, J. Dorfman, Y. Xiao, and M. Morad
Protons Enhance the Gating Kinetics of the alpha 3/beta 4 Neuronal Nicotinic Acetylcholine Receptor by Increasing Its Apparent Affinity to Agonists
Mol. Pharmacol., February 1, 2002; 61(2): 369 - 378.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics